[1] |
Ripollés T, Martínez MJ, Paredes JM, et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy [J]. Radiology, 2009, 253(1): 241-248.
|
[2] |
Vilela EG, Torres HO, Martins FP, et al. Evaluation of inflammatory activity in Crohn′s disease and ulcerative colitis [J]. World J Gastroenterol, 2012, 18(9): 872-881.
|
[3] |
D′Incà R, Caccaro R. Measuring disease activity in Crohn′s disease: what is currently available to the clinician [J]. Clin Exp Gastroenterol, 2014, 7: 151-161.
|
[4] |
Wu KC, Ran ZH, Gao X, et al. Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn′s disease [J]. Intest Res, 2016, 14(2): 152-163.
|
[5] |
Lönnkvist MH, Theodorsson E, Holst M, et al. Blood chemistry markers for evaluation of inflammatory activity in Crohn′s disease during infliximab therapy [J]. Scand J Gastroenterol, 2011, 46(4): 420-427.
|
[6] |
Kiss LS, Papp M, Lovasz BD, et al. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn′s disease: a marker for patient classification? [J]. Inflamm Bowel Dis, 2012, 18(9): 1647-1654.
|
[7] |
Limberg B. Diagnosis of chronic inflammatory bowel disease by ultrasonography [J]. Z Gastroenterol, 1999, 37(6): 495-508.
|
[8] |
Migaleddu V, Scanu AM, Quaia E, et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn′s disease [J]. Gastroenterology, 2009, 137(1): 43-52.
|
[9] |
Knieling F, Neufert C, Hartmann A, et al. Multispectral Optoacoustic Tomography for Assessment of Crohn′s Disease Activity [J]. N Engl J Med, 2017, 376(13): 1292-1294.
|
[10] |
Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies [J]. Radiology, 2008, 247(1): 64-79.
|
[11] |
Ripollés T, Martínez-Pérez MJ, Blanc E, et al. Contrast-enhanced ultrasound (CEUS) in Crohn′s disease: technique, image interpretation and clinical applications [J]. Insights Imaging, 2011, 2(6): 639-652.
|
[12] |
Serra C, Menozzi G, Labate AM, et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn′s disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent [J]. Eur J Radiol, 2007, 62(1): 114-121.
|
[13] |
Strobel D, Goertz RS, Bernatik T. Diagnostics in inflammatory bowel disease: ultrasound [J]. World J Gastroenterol, 2011, 17(27): 3192-3197.
|
[14] |
Theiss AL, Fruchtman S, Lund PK. Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-Ⅰ[J]. Inflamm Bowel Dis, 2004, 10(6): 871-880.
|
[15] |
Ripollés T, Rausell N, Paredes JM, et al. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn′s disease: a comparison with surgical histopathology analysis [J]. J Crohns Colitis, 2013, 7(2): 120-128.
|
[16] |
Romanini L, Passamonti M, Navarria M, et al. Quantitative analysis of contrast-enhanced ultrasonography of the bowel wall can predict disease activity in inflammatory bowel disease [J]. Eur J Radiol, 2014, 83(8): 1317-1323.
|
[17] |
Dietrich CF, Averkiou MA, Correas JM, et al. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion [J]. Ultraschall Med, 2012, 33(4): 344-351.
|